AlphaQuest’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,278
Closed -$29.3K 875
2025
Q4
$29.3K Hold
12,278
﹤0.01% 2044
2025
Q3
$35K Hold
12,278
﹤0.01% 2013
2025
Q2
$46.3K Hold
12,278
﹤0.01% 1645
2025
Q1
$55.6K Sell
12,278
-75,117
-86% -$397K 0.01% 1500
2024
Q4
$618K Buy
87,395
+83,213
+1,990% +$663K 0.08% 388
2024
Q3
$34K Buy
+4,182
New +$30.2K ﹤0.01% 1468
2024
Q2
Sell
-25,550
Closed -$192K 1704
2024
Q1
$192K Sell
25,550
-7,299
-22% -$66.6K 0.03% 653
2023
Q4
$304K Buy
+32,849
New +$268K 0.06% 518

Other funds holding HCAT

AlphaQuest's HCAT Position: Q1 2026 in Review

AlphaQuest sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 12,278 shares — an estimated $29.3K sold.

AlphaQuest first reported a position in HCAT in Q4 2023 and held it in 8 quarters. The position peaked at $618K in Q4 2024. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • AlphaQuest reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 12,278 Health Catalyst shares in Q1 2026, an estimated $29.3K.
  • AlphaQuest first reported a position in Health Catalyst in Q4 2023 and held it in 8 quarters.
  • AlphaQuest's Health Catalyst position peaked at $618K in Q4 2024.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.